
|Articles|September 22, 2022
CRN urges FDA to place greater emphasis on potential benefits of dietary supplements on website
Author(s)Alissa Marrapodi
FDA's content regarding dietary supplements overemphasizing negative aspects of dietary supplement industry, says CRN in feedback to the Agency.
Advertisement
President and CEO of the Council for Responsible Nutrition (CRN; Washington), Steve Mister,per the request of ODS Programs Director Cara Welch, PhD, offered feedback on how dietary supplements are presented on FDA's website and its Supplement Your Knowledge content.
Mister’s critiques of the agency's content included:
- An overemphasis on the potential risks of taking supplements while downplaying the benefits
- Missed opportunities to address public health issues with responsible supplement usage
- A lack of communication on the robust regulatory framework already in place giving the agency authority over supplements, leaving a misimpression that regulation is inadequate
- The current content could be enhanced by collaboration with the industry through CRN in developing future messaging
To read the 11-page letter in full,
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.
Advertisement
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
The paradox in supplement research
2
The role of B6, B12, and folate in one-carbon metabolism and SAMe synthesis
3
How GC Rieber VivoMega is adapting fish and algal omega-3 production to a changing market
4
Gluten labeling under review: GFCO on FDA’s Request for Information
5


